{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:56:27Z","timestamp":1762505787364,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00776-011-0085-8","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T19:57:49Z","timestamp":1305921469000},"page":"313-318","source":"Crossref","is-referenced-by-count":13,"title":["Histological finding of atypical subtrochanteric fracture after long-term alendronate therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"Yoshitomo","family":"Kajino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamon","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1007\/s00776-011-0085-8_bb0010","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1007\/s00776-011-0085-8_bb0015","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"10.1007\/s00776-011-0085-8_bb0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"10.1007\/s00776-011-0085-8_bb0025","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","article-title":"Case reports: two femoral insufficiency fractures after long-term alendronate therapy","volume":"467","author":"Sayed-Noor","year":"2009","journal-title":"Clin Orthop Relat Res."},{"issue":"19","key":"10.1007\/s00776-011-0085-8_bb0030","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMe1003064","article-title":"Evolving data about subtrochanteric fractures and bisphosphonates","volume":"362","author":"Shane","year":"2010","journal-title":"N Engl J Med."},{"issue":"2 Suppl","key":"10.1007\/s00776-011-0085-8_bb0035","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjmed.2008.12.003","article-title":"Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis","volume":"122","author":"Bilezikian","year":"2009","journal-title":"Am J Med."},{"issue":"7","key":"10.1007\/s00776-011-0085-8_bb0040","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s11999-009-1192-0","article-title":"Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy","volume":"468","author":"Cermak","year":"2010","journal-title":"Clin Orthop Relat Res."},{"issue":"3","key":"10.1007\/s00776-011-0085-8_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br."},{"issue":"2","key":"10.1007\/s00776-011-0085-8_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury."},{"issue":"12","key":"10.1007\/s00776-011-0085-8_bb0055","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1007\/s00776-011-0085-8_bb0060","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"10.1007\/s00776-011-0085-8_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1007\/s00776-011-0085-8_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/253432","article-title":"Long-term alendronate use not without consequences?","author":"Somford","year":"2009","journal-title":"Int J Rheumatol."},{"issue":"8","key":"10.1007\/s00776-011-0085-8_bb0075","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res."},{"issue":"3","key":"10.1007\/s00776-011-0085-8_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMc080861","article-title":"More on atypical fractures of the femoral diaphysis","volume":"359","author":"Kwek","year":"2008","journal-title":"N Engl J Med."},{"first-page":"73","year":"2006","series-title":"Japanese Guidelines for the Prevention and Treatment of Osteoporosis 2006 edition","key":"10.1007\/s00776-011-0085-8_bb0085"},{"issue":"11","key":"10.1007\/s00776-011-0085-8_bb0090","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"5","key":"10.1007\/s00776-011-0085-8_bb0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1302\/0301-620X.92B5.22941","article-title":"A rational approach to management of alendronate-related subtrochanteric fractures","volume":"92","author":"Das De","year":"2010","journal-title":"J Bone Joint Surg Br."},{"issue":"10","key":"10.1007\/s00776-011-0085-8_bb0100","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1359\/jbmr.090408","article-title":"Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility","volume":"24","author":"Somford","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"3","key":"10.1007\/s00776-011-0085-8_bb0105","first-page":"317","article-title":"More on atypical fractures of the femoral diaphysis","volume":"359","author":"Lee","year":"2008","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s00776-011-0085-8_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0030-5898(03)00075-0","article-title":"Subtrochanteric femur fractures","volume":"33","author":"Sims","year":"2002","journal-title":"Orthop Clin North Am."},{"key":"10.1007\/s00776-011-0085-8_bb0115","unstructured":". Online version of Gray's anatomy. Available at http:\/\/www.bartleby.com\/107\/59.html. Accessed Oct 20, 2010."},{"issue":"4","key":"10.1007\/s00776-011-0085-8_bb0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res."},{"key":"10.1007\/s00776-011-0085-8_bb0125","unstructured":". Medicines and Healthcare Products Regulatory Agency (MHRA). Bisphosphonate: atypical stress fractures. Drug safety update 2 (8). Available at http:\/\/www.mhra.gov.uk\/Publications\/Safetyguidance\/DrugSafetyUpdate\/CON041211. Accessed Oct 13, 2010."},{"issue":"5","key":"10.1007\/s00776-011-0085-8_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0090-9556(25)08972-X","article-title":"Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals","volume":"19","author":"Lin","year":"1991","journal-title":"Drug Metab Dispos."},{"issue":"24","key":"10.1007\/s00776-011-0085-8_bb0135","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA."},{"key":"10.1007\/s00776-011-0085-8_bb0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","article-title":"Churg\u2013Strauss syndrome","volume":"361","author":"Noth","year":"2003","journal-title":"Lancet."},{"issue":"6","key":"10.1007\/s00776-011-0085-8_bb0145","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"19","key":"10.1007\/s00776-011-0085-8_bb0150","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1007\/s00776-011-0085-8_bb0155","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1359\/jbmr.090527","article-title":"Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate","volume":"24","author":"Dobnig","year":"2009","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815306588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815306588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00776-011-0085-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:29:37Z","timestamp":1741199377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265815306588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0949265815306588"],"URL":"https:\/\/doi.org\/10.1007\/s00776-011-0085-8","relation":{},"ISSN":["0949-2658"],"issn-type":[{"type":"print","value":"0949-2658"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}